Brief: I-Mab Provides Updates On Status Under Holding Foreign Companies Accountable Act
May 5 (Reuters) - I-Mab IMAB.O :
* I-MAB PROVIDES UPDATES ON STATUS UNDER HOLDING FOREIGN
COMPANIES
ACCOUNTABLE ACT
* I-MAB - IN PROCESS OF ENGAGING SELECTED U.S.-BASED
INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM AS PRINCIPAL AUDITOR THAT IS
SUBJECT TO INSPECTION BY PCAOB
* I-MAB - AIMS TO COMPLETE ENGAGEMENT IN SECOND HALF OF 2022
* I-MAB - SUBSEQUENT CHANGE OF PRINCIPAL AUDITOR EXPECTED TO
TAKE
PLACE IN CONJUNCTION WITH FILING OF ANNUAL REPORT FOR FISCAL
YEAR ENDED DEC 31, 2022
Source text for Eikon: ID:nPnb5qSVNa
Further company coverage: IMAB.O
Recent news on NovaBridge Biosciences
See all newsBrief: Visara Secures Exclusive Option For Potential Acquisition Of Yol104-2 For Ocular Surface Squamous Neoplasia
Brief: Visara Expands Ophthalmology Pipeline With Exclusive License For Investigational Nerve Growth Factor Therapy For Neurotrophic Keratitis
Brief: Wuhan Hiteck Biological Pharma Grants Visara Exclusive Rights To HT006.2.2 Outside Greater China
Brief: Novabridge Biosciences Announces Expanded Givastomig Safety And Efficacy Data
NovaBridge Biosciences expected to post a loss of 13 cents a share - Earnings Preview